Literature DB >> 27175462

Vancomycin displays time-dependent eradication of mature Staphylococcus aureus biofilms.

Virginia Post1, Peter Wahl2, R Geoff Richards1, T Fintan Moriarty1.   

Abstract

This study was carried out to determine the time and concentration profile required to achieve vancomycin-mediated eradication of Staphylococcus aureus biofilm. This information is critical for the identification of performance targets for local antibiotic delivery vehicles that target biofilm infections. S. aureus UAMS-1 biofilms were grown for 7 days on titanium-aluminium-niobium discs in Mueller Hinton broth. After 7 days, the discs were then incubated in Mueller Hinton broth containing vancomycin at concentrations of 100, 200, 500, 1,000, and 2,000 mg/L. Biofilm eradication was assessed under both static and shaking conditions. Samples were retrieved at regular intervals for up to 28 days for quantification of residual biofilm. One additional disc was processed per time point for scanning electron microscopy. Progressive and significant reduction of viable bacteria was observed over time at all concentrations compared to unexposed controls. After 28 days under static conditions, the S. aureus biofilm was completely eradicated at 200 mg/L vancomycin and higher concentrations, but not at 100 mg/L. In contrast, bacterial biofilm could not be eradicated under shaking conditions at any concentration. CLINICAL SIGNIFICANCE: The present study shows that it is possible to eradicate mature S. aureus biofilm from metal implants by vancomycin alone although the time concentration profile required cannot be achieved by systemic administration or any of the local delivery vehicles currently available. Identifying targets for antibiotic delivery is the first step in developing fit for purpose local antibiotic delivery vehicles that will successfully and predictably treat established biofilm infection.
© 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 35:381-388, 2017. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  Staphylococcus aureus; biofilm; implant infection; titanium; vancomycin

Mesh:

Substances:

Year:  2016        PMID: 27175462     DOI: 10.1002/jor.23291

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  24 in total

1.  Measuring Antimicrobial Efficacy against Biofilms: a Meta-analysis.

Authors:  Philip S Stewart; Albert E Parker
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

2.  Prospective comparative analysis of efficacy of local debridement with or without vancomycin impregnated calcium sulphate in chronic osteomyelitis.

Authors:  Nuthan Jagadeesh; Ashish Abdul; Vishwanath M Shivalingappa; Hiranya Kumar
Journal:  J Orthop       Date:  2022-06-03

3.  Preclinical evaluation of a commercially available biofilm disrupting wound lavage for musculoskeletal trauma.

Authors:  Michael E Whitely; Sarah M Helms; Preeti J Muire; Alicia L Lofgren; Rebecca A Lopez; Joseph C Wenke
Journal:  J Orthop Surg Res       Date:  2022-07-15       Impact factor: 2.677

4.  Estimation of Minimum Biofilm Eradication Concentration (MBEC) on In Vivo Biofilm on Orthopedic Implants in a Rodent Femoral Infection Model.

Authors:  Yu Okae; Kohei Nishitani; Akio Sakamoto; Toshiyuki Kawai; Takuya Tomizawa; Motoo Saito; Yutaka Kuroda; Shuichi Matsuda
Journal:  Front Cell Infect Microbiol       Date:  2022-07-01       Impact factor: 6.073

5.  Effects of powdered rifampin and vancomycin solutions on biofilm production of staphylococcus aureus on orthopedic implants.

Authors:  Christian Douthit; Brent Gudenkauf; Abdul Hamood; Nithya Mudaliar; Cyrus Caroom; Mark Jenkins
Journal:  J Clin Orthop Trauma       Date:  2019-10-13

6.  Adjuvant antibiotic-loaded bone cement: Concerns with current use and research to make it work.

Authors:  Edward M Schwarz; Alex C McLaren; Thomas P Sculco; Barry Brause; Mathias Bostrom; Stephen L Kates; Javad Parvizi; Volker Alt; William V Arnold; Alberto Carli; Antonia F Chen; Hyonmin Choe; Débora C Coraça-Huber; Michael Cross; Michelle Ghert; Noreen Hickok; Jessica Amber Jennings; Manjari Joshi; Willem-Jan Metsemakers; Mark Ninomiya; Kohei Nishitani; Irvin Oh; Douglas Padgett; Benjamin Ricciardi; Kordo Saeed; Parham Sendi; Bryan Springer; Paul Stoodley; Joseph C Wenke
Journal:  J Orthop Res       Date:  2020-03-02       Impact factor: 3.102

7.  Tolerant Small-colony Variants Form Prior to Resistance Within a Staphylococcus aureus Biofilm Based on Antibiotic Selective Pressure.

Authors:  Robert Manasherob; Jake A Mooney; David W Lowenberg; Paul L Bollyky; Derek F Amanatullah
Journal:  Clin Orthop Relat Res       Date:  2021-07-01       Impact factor: 4.755

Review 8.  Allograft Bone as Antibiotic Carrier.

Authors:  Heinz Winkler; Peter Haiden
Journal:  J Bone Jt Infect       Date:  2017-01-01

9.  Treatment of chronic orthopaedic infection.

Authors:  Heinz Winkler
Journal:  EFORT Open Rev       Date:  2017-05-11

10.  Differential Activity of the Combination of Vancomycin and Amikacin on Planktonic vs. Biofilm-Growing Staphylococcus aureus Bacteria in a Hollow Fiber Infection Model.

Authors:  Diane C Broussou; Marlène Z Lacroix; Pierre-Louis Toutain; Frédérique Woehrlé; Farid El Garch; Alain Bousquet-Melou; Aude A Ferran
Journal:  Front Microbiol       Date:  2018-03-27       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.